2024 Q4 Form 10-Q Financial Statement

#000091678924000037 Filed on October 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $530.7M $474.2M
YoY Change -3.44% -3.53%
Cost Of Revenue $271.4M $258.2M
YoY Change -5.06% -1.44%
Gross Profit $259.3M $216.1M
YoY Change -1.69% -5.91%
Gross Profit Margin 48.86% 45.56%
Selling, General & Admin $180.7M $179.7M
YoY Change 18.13% 0.28%
% of Gross Profit 69.68% 83.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.79M
YoY Change -0.71%
% of Gross Profit 6.38%
Operating Expenses $180.7M $179.7M
YoY Change 18.13% 0.28%
Operating Profit $75.12M $34.85M
YoY Change -29.75% -25.6%
Interest Expense -$13.22M
YoY Change -196.79%
% of Operating Profit -37.92%
Other Income/Expense, Net $198.0K $170.0K
YoY Change 10.0% 14.86%
Pretax Income $63.15M $21.81M
YoY Change -32.99% -34.59%
Income Tax $13.54M $4.792M
% Of Pretax Income 21.43% 21.98%
Net Earnings $49.62M $17.01M
YoY Change -34.63% -37.86%
Net Earnings / Revenue 9.35% 3.59%
Basic Earnings Per Share $2.17 $0.75
Diluted Earnings Per Share $2.17 $0.74
COMMON SHARES
Basic Shares Outstanding 22.85M shares 22.81M shares
Diluted Shares Outstanding 22.88M shares 22.84M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.14M
YoY Change -16.79%
Cash & Equivalents $40.80M $20.14M
Short-Term Investments
Other Short-Term Assets $29.91M
YoY Change 3.13%
Inventory $450.7M $469.6M
Prepaid Expenses
Receivables $456.2M $365.7M
Other Receivables $15.29M
Total Short-Term Assets $996.3M $900.6M
YoY Change 4.17% 1.34%
LONG-TERM ASSETS
Property, Plant & Equipment $329.8M $331.5M
YoY Change -1.63% -1.44%
Goodwill $1.067B $1.067B
YoY Change 0.0% 0.0%
Intangibles $524.1M $528.5M
YoY Change -3.13% -3.02%
Long-Term Investments
YoY Change
Other Assets $16.85M $14.49M
YoY Change 42.19% 101.18%
Total Long-Term Assets $1.977B $1.980B
YoY Change -0.95% -1.65%
TOTAL ASSETS
Total Short-Term Assets $996.3M $900.6M
Total Long-Term Assets $1.977B $1.980B
Total Assets $2.973B $2.880B
YoY Change 0.71% -0.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $315.4M $323.3M
YoY Change 7.61% 24.97%
Accrued Expenses $182.8M $163.7M
YoY Change -21.06% -16.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $8.594M $7.813M
YoY Change 37.83% 25.31%
Total Short-Term Liabilities $517.8M $508.7M
YoY Change -4.77% 7.68%
LONG-TERM LIABILITIES
Long-Term Debt $725.3M $705.4M
YoY Change -0.56% -15.89%
Other Long-Term Liabilities $11.48M $12.28M
YoY Change -10.42% -5.07%
Total Long-Term Liabilities $736.8M $717.7M
YoY Change -0.73% -15.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $517.8M $508.7M
Total Long-Term Liabilities $736.8M $717.7M
Total Liabilities $1.345B $1.313B
YoY Change -1.54% -6.21%
SHAREHOLDERS EQUITY
Retained Earnings $1.261B $1.211B
YoY Change 1.56% 3.92%
Common Stock $364.1M $357.9M
YoY Change 6.23% 7.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.628B $1.568B
YoY Change
Total Liabilities & Shareholders Equity $2.973B $2.880B
YoY Change 0.71% -0.73%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $49.62M $17.01M
YoY Change -34.63% -37.86%
Depreciation, Depletion And Amortization $13.79M
YoY Change -0.71%
Cash From Operating Activities $44.60M
YoY Change 21.85%
INVESTING ACTIVITIES
Capital Expenditures $4.884M
YoY Change -43.86%
Acquisitions
YoY Change
Other Investing Activities -$56.00K
YoY Change
Cash From Investing Activities -$4.940M
YoY Change -43.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -35.67M
YoY Change -16.47%
NET CHANGE
Cash From Operating Activities 44.60M
Cash From Investing Activities -4.940M
Cash From Financing Activities -35.67M
Net Change In Cash 3.989M
YoY Change -126.95%
FREE CASH FLOW
Cash From Operating Activities $44.60M
Capital Expenditures $4.884M
Free Cash Flow $39.71M
YoY Change 42.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22814811 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22814811 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23751258 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23751258 shares
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
50089000 usd
CY2023Q3 hele Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect
StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect
7229000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1501883000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1637442000 usd
CY2024Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
6204000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
698000 usd
CY2024Q2 hele Stock Issued During Period Value Stock Options Exercised Net Of Tax Effect
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxEffect
352000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2006000 usd
us-gaap Profit Loss
ProfitLoss
23218000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27628000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
639000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5840000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
112000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5391000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71990000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10317000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-9595000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
157732000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
20557000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
261150000 usd
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
27381000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2454000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
441000 usd
CY2023Q2 hele Stock Issued During Period Value Stock Options Exercised Net Of Tax Effect
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxEffect
212000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4446000 usd
CY2023Q2 hele Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect
StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect
9297000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1514908000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
103035000 usd
CY2024Q2 hele Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect
StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect
5833000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1549500000 usd
CY2024Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
17014000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4312000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
109000 usd
CY2024Q3 hele Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect
StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect
5487000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1567580000 usd
us-gaap Profit Loss
ProfitLoss
49962000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24606000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
616000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3941000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3671000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11320000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16526000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
29000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
246000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
9039000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
6845000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-26340000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
14427000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
73630000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-19804000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5805000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
253000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
78922000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-22529000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-10708000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69916000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14026000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1363000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0 usd
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
1249000 usd
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
39000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
246000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14101000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20311000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
509930000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
459880000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
348150000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3125000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3125000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
318000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
hele Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options And Tax Benefits
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAndTaxBenefits
2358000 usd
hele Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options And Tax Benefits
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAndTaxBenefits
2380000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
103144000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
54535000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54179000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142280000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1636000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4859000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18501000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29073000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20137000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24214000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7767000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2790000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2024Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19740000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36572000 usd
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
39984000 usd
CY2024Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
37851000 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
20910000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
21282000 usd
CY2024Q3 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
27503000 usd
CY2024Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
29212000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
55547000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
56474000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
163684000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
181391000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5266000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6844000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
10835000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
15500000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2024Q3 hele Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Target Achievement As A Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTargetAchievementAsAPercentage
0
CY2024Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 usd
CY2024Q3 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
245300000 usd
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
500000000 usd
CY2021Q4 hele Loss Contingency Number Of Other Defendants
LossContingencyNumberOfOtherDefendants
5 renewal
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5640000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6279000 usd
CY2024Q3 hele Long Term Debt Less Unamortized Prepaid Financing Fees
LongTermDebtLessUnamortizedPrepaidFinancingFees
713235000 usd
CY2024Q1 hele Long Term Debt Less Unamortized Prepaid Financing Fees
LongTermDebtLessUnamortizedPrepaidFinancingFees
665671000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7813000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6250000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
705422000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
659421000 usd
CY2024Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
13200000 usd
CY2023Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
13700000 usd
CY2024Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
25800000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 usd
us-gaap Interest Costs Incurred
InterestCostsIncurred
28600000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
900000 usd
CY2024Q1 hele Debt Instrument Restrictive Covenant Maximum Net Leverage Ratio
DebtInstrumentRestrictiveCovenantMaximumNetLeverageRatio
3.25
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
100000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-4852000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
4865000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
772000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1644000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-2668000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
1764000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
2040000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
3389000 usd
CY2024Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
66000 usd
CY2023Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-16000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
88000 usd
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-40000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
1764000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
3389000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Tax
OtherComprehensiveIncomeLossBeforeReclassificationsTax
-364000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1261000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-2668000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
2040000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Tax
OtherComprehensiveIncomeLossBeforeReclassificationsTax
-1094000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3614000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
474221000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
491563000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
891068000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
966235000 usd
CY2024Q3 hele Income Tax Expense Benefit Percentage Of Income Before Income Taxes
IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes
0.220
CY2023Q3 hele Income Tax Expense Benefit Percentage Of Income Before Income Taxes
IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes
0.179
hele Income Tax Expense Benefit Percentage Of Income Before Income Taxes
IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes
0.421
hele Income Tax Expense Benefit Percentage Of Income Before Income Taxes
IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes
0.168
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22814000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23918000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23169000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23984000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
25000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
123000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
67000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
104000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22839000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24041000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23236000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24088000 shares
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
hele-20240831_def.xml Edgar Link unprocessable
0000916789-24-000037-index-headers.html Edgar Link pending
0000916789-24-000037-index.html Edgar Link pending
0000916789-24-000037.txt Edgar Link pending
0000916789-24-000037-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fy25_q2xexhibit311.htm Edgar Link pending
fy25_q2xexhibit312.htm Edgar Link pending
fy25_q2xexhibit32.htm Edgar Link pending
hele-20240831.htm Edgar Link pending
hele-20240831.xsd Edgar Link pending
hele-20240831_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hele-20240831_cal.xml Edgar Link unprocessable
hele-20240831_lab.xml Edgar Link unprocessable
hele-20240831_pre.xml Edgar Link unprocessable
hele-20240831_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending